Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

palliative radiotherapy

  • You have access
    Quality of Life Following Stereotactic Body Radiotherapy Versus Three-Dimensional Conformal Radiotherapy for Vertebral Metastases: Secondary Analysis of an Exploratory Phase II Randomized Trial
    TANJA SPRAVE, VIVEK VERMA, ROBERT FÖRSTER, INGMAR SCHLAMPP, THOMAS BRUCKNER, TILMAN BOSTEL, RAMI ATEAYH EL SHAFIE, NILS HENRIK NICOLAY, JÜRGEN DEBUS and HARALD RIEF
    Anticancer Research August 2018, 38 (8) 4961-4968; DOI: https://doi.org/10.21873/anticanres.12814
  • You have access
    Patient-reported Symptom Burden, Rate of Completion of Palliative Radiotherapy and 30-day Mortality in Two Groups of Cancer Patients Managed With or Without Additional Care by a Multidisciplinary Palliative Care Team
    CARSTEN NIEDER, ASTRID DALHAUG, ELLINOR HAUKLAND and KIRSTEN ENGLJÄHRINGER
    Anticancer Research April 2018, 38 (4) 2271-2275;
  • You have access
    Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models
    CARSTEN NIEDER and THOMAS A. KÄMPE
    Anticancer Research March 2018, 38 (3) 1705-1709;
  • You have access
    Does Patient-reported Dyspnea Reflect Thoracic Disease Characteristics in Patients with Incurable Cancer?
    CARSTEN NIEDER, THOMAS A. KÄMPE and KIRSTEN ENGLJÄHRINGER
    Anticancer Research February 2018, 38 (2) 901-904;
  • You have access
    Validation of a Score Developed to Estimate the 6-month Survival of Patients Treated with Palliative Local Radiotherapy for Advanced Lung Cancer
    STEFAN JANSSEN, BIRGITT VAN OORSCHOT, LUKAS KÄSMANN, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research May 2017, 37 (5) 2537-2540;
  • You have access
    Polypharmacy in Older Patients ≥70 Years Receiving Palliative Radiotherapy
    CARSTEN NIEDER, BĂRD MANNSĂKER, ADAM PAWINSKI and ELLINOR HAUKLAND
    Anticancer Research February 2017, 37 (2) 795-799;
  • You have access
    Palliation of Ulcerative Breast Lesions with Radiation
    PRASHANT VEMPATI, MIRIAM A. KNOLL, KAVITA DHARMARAJAN, SHERYL GREEN, AMY TIERSTEN and RICHARD L. BAKST
    Anticancer Research September 2016, 36 (9) 4701-4705;
  • You have access
    Survival After Palliative Radiotherapy in Geriatric Cancer Patients
    CARSTEN NIEDER, KENT ANGELO, ELLINOR HAUKLAND and ADAM PAWINSKI
    Anticancer Research November 2014, 34 (11) 6641-6645;
  • You have access
    Development and Validation of a Model Predicting Short Survival (Death Within 30 Days) After Palliative Radiotherapy
    KENT ANGELO, JAN NORUM, ASTRID DALHAUG, ADAM PAWINSKI, GRO AANDAHL, ELLINOR HAUKLAND, KIRSTEN ENGLJÄHRINGER and CARSTEN NIEDER
    Anticancer Research February 2014, 34 (2) 877-885;

Pages

  • Previous
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire